Biomaterials are substances that can be injected, implanted, or applied to the surface of
tissues in biomedical applications and have the ability to interact with biological systems to …

Despite recent advancements in cancer treatment, this disease still poses a serious threat to
public health. Vaccines play an important role in preventing illness by preparing the body's …

After more than a century since its initial development, Bacille Calmette‐Guérin (BCG)
remains the only licensed vaccine against tuberculosis (TB). Subunit boosters are …

Breast and gynecologic cancers are significant global threats to women's health and those
living with the disease require lifelong physical, financial, and social support from their …

Control of the intracellular parasite Leishmania (L.) requires the activation of strong type 1
cellular immune responses. Towards this goal, in the present study, a multiepitope chimeric …

Clinically, multimodal therapies are adopted worldwide for the management of cancer,
which continues to be a leading cause of death. In recent years, immunotherapy has firmly …

Human papillomaviruses (HPVs) are well-known causative agents of several cancers, yet
selective therapies remain under investigation. Nanoparticles, for instance, are emerging as …

Subunit vaccines require an immunostimulant (adjuvant) and/or delivery system to induce
immunity. However, currently, available adjuvants are either too dangerous in terms of side …

Cervical cancer, among the deadliest cancers affecting women globally, primarily arises
from persistent infection with high-risk human papillomavirus (HPV). To effectively combat …

Proteins and peptides are on the rise as therapeutic agents and represent a higher
percentage of approved drugs each year: 24% in 2021 vs. 13% in 2016 [1]. These classes of …